In conclusion, we demonstrated that anti-ceramide antibody levels were elevated, while S1P concentrations were decreased in patients with obstructive sleep apnea compared to subjects without OSA. The gene discussed is MBTPS1; the disease is obstructive sleep apnea syndrome.